← All trials
NCT06353477
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2019
- Primary completion
- Jun 1, 2022
- Completion date
- Jan 1, 2023
- First posted
- Apr 9, 2024
- Last posted
- Apr 9, 2024
- Enrollment
- 240
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Eskisehir Osmangazi UniversityLead sponsor
- Abdi Ibrahim PharmaceuticalsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.